XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net loss $ (6,101) $ (4,836)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation of property and equipment 27 42
Interest income and unrealized gains from marketable securities (119)
Share-based compensation 493 784
Changes in assets and liabilities:    
Prepaid expenses and other assets 161 (215)
Other payables and accrued liabilities 92 (387)
Insurance recovery related to legal settlement and legal expenses received in cash 1,335
Legal settlement paid in cash (1,100)
Net cash flows used in operating activities (5,447) (4,377)
Investing activities:    
Purchases of property and equipment (22) (18)
Purchases of marketable securities (31,918) (5,120)
Proceeds from sales of marketable securities 5,801 2,540
Proceeds from maturities of marketable securities 2,500
Net cash flows used in investing activities (26,139) (98)
Financing activities:    
Issuance of common stock and warrants, net 32,558 4,471
Net cash flows provided by financing activities 32,558 4,471
Increase (decrease) in cash, cash equivalents and restricted cash 972 (4)
Cash, cash equivalents and restricted cash at beginning of period 3,163 2,517
Cash, cash equivalents and restricted cash at end of period 4,135 2,513
Supplemental disclosure of non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for lease liabilities 89 37
Issuance expenses not paid 93 52
Legal settlement settled through issuance of common stock 1,111
Accrued bonus settled through grant of stock-option awards 76
Deferred issuance expenses 30 138
Supplemental disclosure of cash flow information:    
Cash and cash equivalents 4,082 2,465
Restricted cash 53 48
Cash, cash equivalents and restricted cash $ 4,135 $ 2,513